Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial – ET HealthWorld

NEW DELHI: Pharmaceutical major Mylan NV on Monday said it has received approval from Indian drugs regulator DCGI to manufacture and market its remdesivir for restricted emergency use in the country for the treatment of COVID-19. The drug will be priced at Rs 4,800 per 100 mg vial and would be available to the patients […]

Screen COVID-19 patients for blood clotting abnormalities: Study - ET HealthWorld

Screen COVID-19 patients for blood clotting abnormalities: Study – ET HealthWorld

New York: Saying that critically ill COVID-19 patients may be at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke, researchers have emphasised on the need for early screening. Thromboelastography (TEG) is a whole blood assay that provides a broad picture of how an individual […]

USFDA Looks for Ways to Speed up Plant Inspections - ET HealthWorld

USFDA Looks for Ways to Speed up Plant Inspections – ET HealthWorld

Mumbai: The US Food and Drug Administration is considering alternative approaches for inspections of manufacturing sites, acting upon requests from several companies, including Indian drug makers, to address the issue. The move has been triggered by the shortage of drugs — most of them supplied by Indian generic drug companies — that the US faces […]